Status: Recruiting
A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
This is a prospective, multi-center, randomized trial designed to investigate the efficacy and safety of Sperstent® peripheral spot stent system versus Everflex® self-expanding peripheral stent system in the endovascular treatment of post-balloon angioplasty (post-PTA) residual lesions including stenoses and/or dissections in femoral and proximal popliteal arteries.
Participants needed: 240
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: FrontAce Scientific Co., LtdUpdated: Aug 6, 2024Locations: 12
Eligibility criteria
Age 18-85 years old, male or female; [+9]
Target vessel had undergone open surgery such as bypass surgery or the target le... [+19]